Works matching AU Fabi, Alessandra


Results: 137
    1
    2

    Prognostic implications of risk definitions from the monarchE and NATALEE trials Open Access.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 6, p. 1198, doi. 10.1093/jnci/djaf031
    By:
    • Arecco, Luca;
    • Blondeaux, Eva;
    • Bruzzone, Marco;
    • Arpino, Grazia;
    • Angelis, Carmine De;
    • Laurentiis, Michelino De;
    • Caputo, Roberta;
    • Fabi, Alessandra;
    • Sanna, Valeria;
    • Gori, Stefania;
    • Puglisi, Fabio;
    • Boni, Luca;
    • Nardin, Simone;
    • Giannubilo, Irene;
    • Perachino, Marta;
    • Borea, Roberto;
    • Agostinetto, Elisa;
    • Azambuja, Evandro de;
    • Lambertini, Matteo;
    • Mastro, Lucia Del
    Publication type:
    Article
    3

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    4
    5

    Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1715, doi. 10.3390/cancers17101715
    By:
    • Cazzaniga, Marina Elena;
    • Pronzato, Paolo;
    • Amoroso, Domenico;
    • Arpino, Grazia;
    • Atzori, Francesco;
    • Beano, Alessandra;
    • Biganzoli, Laura;
    • Bisagni, Giancarlo;
    • Blasi, Livio;
    • Capello, Cristina;
    • Chiari, Rita;
    • D'Alonzo, Alessia;
    • De Laurentiis, Michelino;
    • Denaro, Angela;
    • Fabi, Alessandra;
    • Farci, Daniele;
    • Ferraù, Francesco;
    • Fiorio, Elena;
    • Gennari, Alessandra;
    • Giotta, Francesco
    Publication type:
    Article
    6

    Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00801-3
    By:
    • Fabi, Alessandra;
    • Rossi, Alessandro;
    • Caputo, Roberta;
    • Pisegna, Simona;
    • Scagnoli, Simone;
    • Pantano, Francesco;
    • D'Auria, Giuliana;
    • Fedele, Palma;
    • Fabbri, Agnese;
    • Vernieri, Claudio;
    • Palleschi, Michela;
    • Carbognin, Luisa;
    • Ferretti, Gianluigi;
    • Di Monte, Elena;
    • Paris, Ida;
    • Pavese, Francesco;
    • Garrone, Ornella;
    • Franco, Antonio;
    • De Laurentiis, Michelino;
    • Franceschini, Gianluca
    Publication type:
    Article
    7
    8

    p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.

    Published in:
    2020
    By:
    • Fabi, Alessandra;
    • Mottolese, Marcella;
    • Di Benedetto, Anna;
    • Sperati, Francesca;
    • Ercolani, Cristiana;
    • Buglioni, Simonetta;
    • Nisticò, Cecilia;
    • Ferretti, Gianluigi;
    • Vici, Patrizia;
    • Perracchio, Letizia;
    • Malaguti, Paola;
    • Russillo, Michelangelo;
    • Botti, Claudio;
    • Pescarmona, Edoardo;
    • Cognetti, Francesco;
    • Terrenato, Irene
    Publication type:
    journal article
    9

    The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.

    Published in:
    2019
    By:
    • Gori, Stefania;
    • Puglisi, Fabio;
    • Moroso, Stefano;
    • Fabi, Alessandra;
    • La Verde, Nicla;
    • Frassoldati, Antonio;
    • Tarenzi, Emiliana;
    • Garrone, Ornella;
    • Vici, Patrizia;
    • Laudadio, Lucio;
    • Cretella, Elisabetta;
    • Turazza, Monica;
    • Foglietta, Jennifer;
    • Leonardi, Vita;
    • Cavanna, Luigi;
    • Barni, Sandro;
    • Galanti, Daniele;
    • Russo, Antonio;
    • Marchetti, Fabiana;
    • Valerio, Matteo
    Publication type:
    journal article
    10
    11

    Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.

    Published in:
    Targeted Oncology, 2022, v. 17, n. 6, p. 615, doi. 10.1007/s11523-022-00913-x
    By:
    • De Laurentiis, Michelino;
    • Caputo, Roberta;
    • Mazza, Manuelita;
    • Mansutti, Mauro;
    • Masetti, Riccardo;
    • Ballatore, Zelmira;
    • Torrisi, Rosalba;
    • Michelotti, Andrea;
    • Zambelli, Alberto;
    • Ferro, Antonella;
    • Generali, Daniele;
    • Vici, Patrizia;
    • Coltelli, Luigi;
    • Fabi, Alessandra;
    • Marchetti, Paolo;
    • Ballestrero, Alberto;
    • Spazzapan, Simon;
    • Frassoldati, Antonio;
    • Sarobba, Maria Giuseppina;
    • Grasso, Donatella
    Publication type:
    Article
    12

    Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-164
    By:
    • Del Mastro, Lucia;
    • Fabi, Alessandra;
    • Mansutti, Mauro;
    • De Laurentiis, Michele;
    • Durando, Antonio;
    • Merlo, Domenico Franco;
    • Bruzzi, Paolo;
    • La Torre, Ignazia;
    • Ceccarelli, Matteo;
    • Kazeem, Gbenga;
    • Marchi, Paolo;
    • Boy, Davide;
    • Venturini, Marco;
    • De Placido, Sabino;
    • Cognetti, Francesco
    Publication type:
    Article
    13

    Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.

    Published in:
    2013
    By:
    • Del Mastro, Lucia;
    • Fabi, Alessandra;
    • Mansutti, Mauro;
    • De Laurentiis, Michele;
    • Durando, Antonio;
    • Merlo, Domenico Franco;
    • Bruzzi, Paolo;
    • La Torre, Ignazia;
    • Ceccarelli, Matteo;
    • Kazeem, Gbenga;
    • Marchi, Paolo;
    • Boy, Davide;
    • Venturini, Marco;
    • De Placido, Sabino;
    • Cognetti, Francesco
    Publication type:
    journal article
    14

    Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.

    Published in:
    BMC Cancer, 2012, v. 12, n. 1, p. 482, doi. 10.1186/1471-2407-12-482
    By:
    • Fabi, Alessandra;
    • Russillo, Michelangelo;
    • Feretti, Gianluigi;
    • Metro, Giulio;
    • Nistic•, Cecilia;
    • Papaldo, Paola;
    • De Vita, Ferdinando;
    • D'Auria, Giuliana;
    • Vidiri, Antonello;
    • Giannarelli, Diana;
    • Cognetti, Francesco
    Publication type:
    Article
    15
    16

    Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.

    Published in:
    Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01438-z
    By:
    • Allegretti, Matteo;
    • Fabi, Alessandra;
    • Giordani, Elena;
    • Ercolani, Cristiana;
    • Romania, Paolo;
    • Nisticò, Cecilia;
    • Gasparro, Simona;
    • Barberi, Vittoria;
    • Ciolina, Maria;
    • Pescarmona, Edoardo;
    • Giannarelli, Diana;
    • Ciliberto, Gennaro;
    • Cognetti, Francesco;
    • Giacomini, Patrizio
    Publication type:
    Article
    17
    18
    19
    20

    Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1501667
    By:
    • Gori, Stefania;
    • Fabi, Alessandra;
    • Angiolini, Catia;
    • Turazza, Monica;
    • Salvini, Piermario;
    • Ferretti, Gianluigi;
    • Cretella, Elisabetta;
    • Gianni, Lorenzo;
    • Bighin, Claudia;
    • Toss, Angela;
    • Zamagni, Claudio;
    • Vici, Patrizia;
    • De Rossi, Costanza;
    • Russo, Antonio;
    • Bisagni, Giancarlo;
    • Schirone, Alessio;
    • Borgato, Lucia;
    • Cariello, Anna;
    • Cappelletti, Claudia;
    • Bordonaro, Roberto
    Publication type:
    Article
    21

    Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.

    Published in:
    2022
    By:
    • La Verde, Nicla;
    • Damia, Giovanna;
    • Garrone, Ornella;
    • Santini, Daniele;
    • Fabi, Alessandra;
    • Ciccarese, Mariangela;
    • Generali, Daniele Giulio;
    • Nunzi, Martina;
    • Poletto, Elena;
    • Ferraris, Elisa;
    • Cretella, Elisabetta;
    • Scandurra, Giuseppa;
    • Meattini, Icro;
    • Bertolini, Alessandro Stefano;
    • Cavanna, Luigi;
    • Collovà, Elena;
    • Romagnoli, Emanuela;
    • Rulli, Eliana;
    • Legramandi, Lorenzo;
    • Guffanti, Federica
    Publication type:
    journal article
    22
    23
    24

    Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients.

    Published in:
    Oncology, 2005, v. 69, n. 1, p. 35, doi. 10.1159/000087286
    By:
    • Ferretti, Gianluigi;
    • Fabi, Alessandra;
    • Carlini, Paolo;
    • Papaldo, Paola;
    • Fei, Paola Cordiali;
    • Di Cosimo, Serena;
    • Salesi, Nello;
    • Giannarelli, Diana;
    • Alimonti, Andrea;
    • Di Cocco, Barbara;
    • D'Agosto, Giovanna;
    • Bordignon, Valentina;
    • Trento, Elisabetta;
    • Cognetti, Francesco
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    New aromatase inhibitors as second‐line endocrine therapy in postmenopausal patients with metastatic breast carcinomaPresented at the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 5–8, 2004.: A pooled analysis of the randomized trials

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1335, doi. 10.1002/cncr.21339
    By:
    • Paolo Carlini;
    • Emilio Bria;
    • Diana Giannarelli;
    • Gianluigi Ferretti;
    • Alessandra Felici;
    • Paola Papaldo;
    • Alessandra Fabi;
    • Cecilia Nisticò;
    • Serena Di Cosimo;
    • Enzo Maria Ruggeri;
    • Michele Milella;
    • Marcella Mottolese;
    • Edmondo Terzoli;
    • Francesco Cognetti
    Publication type:
    Article
    31
    32
    33
    34

    Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 717, doi. 10.1007/s00280-007-0650-1
    By:
    • Fabi, Alessandra;
    • Metro, Giulio;
    • Papaldo, Paola;
    • Mottolese, Marcella;
    • Melucci, Elisa;
    • Carlini, Paolo;
    • Sperduti, Isabella;
    • Russillo, Michelangelo;
    • Gelibter, Alain;
    • Ferretti, Gianluigi;
    • Tomao, Silverio;
    • Milella, Michele;
    • Cognetti, Francesco
    Publication type:
    Article
    35

    Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 615, doi. 10.1007/s00280-005-0116-2
    By:
    • Fabi, Alessandra;
    • Ferretti, Gianluigi;
    • Papaldo, Paola;
    • Salesi, Nello;
    • Ciccarese, Mariangela;
    • Lorusso, Vito;
    • Carlini, Paolo;
    • Carpino, Armando;
    • Mottolese, Marcella;
    • Cianciulli, Anna Maria;
    • Giannarelli, Diana;
    • Sperduti, Isabella;
    • Felici, Alessandra;
    • Cognetti, Francesco
    Publication type:
    Article
    36
    37

    Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis.

    Published in:
    Minerva Surgery, 2021, v. 76, n. 6, p. 506, doi. 10.23736/S2724-5691.21.09007-9
    By:
    • ORLANDI, Armando;
    • D’ARCHI, Sabatino;
    • GARUFI, Giovanna;
    • FRANCO, Antonio;
    • CARNASSALE, Beatrice;
    • PALAZZO, Antonella;
    • BRIA, Emilio;
    • SANCHEZ, Martin;
    • LEONE, Alba DI;
    • TERRIBILE, Daniela;
    • FABI, Alessandra;
    • TORTORA, Giampaolo;
    • MASETTI, Riccardo;
    • FRANCESCHINI, Gianluca
    Publication type:
    Article
    38

    Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy.

    Published in:
    NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00727-w
    By:
    • Mastrantoni, Luca;
    • Garufi, Giovanna;
    • Giordano, Giulia;
    • Maliziola, Noemi;
    • Di Monte, Elena;
    • Arcuri, Giorgia;
    • Frescura, Valentina;
    • Rotondi, Angelachiara;
    • Orlandi, Armando;
    • Carbognin, Luisa;
    • Palazzo, Antonella;
    • Miglietta, Federica;
    • Pontolillo, Letizia;
    • Fabi, Alessandra;
    • Gerratana, Lorenzo;
    • Pannunzio, Sergio;
    • Paris, Ida;
    • Pilotto, Sara;
    • Marazzi, Fabio;
    • Franco, Antonio
    Publication type:
    Article
    39

    Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00713-8
    By:
    • Cucciniello, Linda;
    • Blondeaux, Eva;
    • Bighin, Claudia;
    • Gasparro, Simona;
    • Russo, Stefania;
    • Dri, Arianna;
    • Pugliese, Palma;
    • Fontana, Andrea;
    • Cortesi, Enrico;
    • Ferzi, Antonella;
    • Riccardi, Ferdinando;
    • Sini, Valentina;
    • Boni, Luca;
    • Fabi, Alessandra;
    • Montemurro, Filippo;
    • De Laurentiis, Michelino;
    • Arpino, Grazia;
    • Del Mastro, Lucia;
    • Gerratana, Lorenzo;
    • Puglisi, Fabio
    Publication type:
    Article
    40

    Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00657-z
    By:
    • Scagnoli, Simone;
    • Pisegna, Simona;
    • Toss, Angela;
    • Caputo, Roberta;
    • De Laurentiis, Michelino;
    • Palleschi, Michela;
    • de Giorgi, Ugo;
    • Cortesi, Enrico;
    • Fabbri, Agnese;
    • Fabi, Alessandra;
    • Paris, Ida;
    • Orlandi, Armando;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Garrone, Ornella;
    • Tomasello, Gianluca;
    • D'Auria, Giuliana;
    • Vici, Patrizia;
    • Ricevuto, Enrico;
    • Domati, Federica
    Publication type:
    Article
    41

    Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

    Published in:
    2024
    By:
    • Scagnoli, Simone;
    • Pisegna, Simona;
    • Toss, Angela;
    • Caputo, Roberta;
    • De Laurentiis, Michelino;
    • Palleschi, Michela;
    • de Giorgi, Ugo;
    • Cortesi, Enrico;
    • Fabbri, Agnese;
    • Fabi, Alessandra;
    • Paris, Ida;
    • Orlandi, Armando;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Garrone, Ornella;
    • Tomasello, Gianluca;
    • D'Auria, Giuliana;
    • Vici, Patrizia;
    • Ricevuto, Enrico;
    • Domati, Federica
    Publication type:
    Correction Notice
    42

    Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00657-z
    By:
    • Scagnoli, Simone;
    • Pisegna, Simona;
    • Toss, Angela;
    • Caputo, Roberta;
    • De Laurentiis, Michelino;
    • Palleschi, Michela;
    • de Giorgi, Ugo;
    • Cortesi, Enrico;
    • Fabbri, Agnese;
    • Fabi, Alessandra;
    • Paris, Ida;
    • Orlandi, Armando;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Garrone, Ornella;
    • Tomasello, Gianluca;
    • D'Auria, Giuliana;
    • Vici, Patrizia;
    • Ricevuto, Enrico;
    • Domati, Federica
    Publication type:
    Article
    43

    Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

    Published in:
    2024
    By:
    • Fabi, Alessandra;
    • Carbognin, Luisa;
    • Botticelli, Andrea;
    • Paris, Ida;
    • Fuso, Paola;
    • Savastano, Maria Cristina;
    • La Verde, Nicla;
    • Strina, Carla;
    • Pedersini, Rebecca;
    • Guarino, Stefania;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Raffaele, Mimma;
    • Beano, Alessandra;
    • Franco, Antonio;
    • Valerio, Maria Rosaria;
    • Verderame, Francesco;
    • Fontana, Andrea;
    • Haspinger, Eva Regina;
    • Caldara, Alessia
    Publication type:
    Correction Notice
    44

    Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

    Published in:
    2023
    By:
    • Fabi, Alessandra;
    • Carbognin, Luisa;
    • Botticelli, Andrea;
    • Paris, Ida;
    • Fuso, Paolo;
    • Savastano, Maria Cristina;
    • La Verde, Nicla;
    • Strina, Carla;
    • Pedersini, Rebecca;
    • Guarino, Stefania;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Raffaele, Mimma;
    • Beano, Alessandra;
    • Franco, Antonio;
    • Valerio, Maria Rosaria;
    • Verderame, Francesco;
    • Fontana, Andrea;
    • Haspinger, Eva Regina;
    • Caldara, Alessia
    Publication type:
    Correction Notice
    45

    Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
    By:
    • Fabi, Alessandra;
    • Carbognin, Luisa;
    • Botticelli, Andrea;
    • Paris, Ida;
    • Fuso, Paolo;
    • Savastano, Maria Cristina;
    • La Verde, Nicla;
    • Strina, Carla;
    • Pedersini, Rebecca;
    • Guarino, Stefania;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Raffaele, Mimma;
    • Beano, Alessandra;
    • Franco, Antonio;
    • Valerio, Maria Rosaria;
    • Verderame, Francesco;
    • Fontana, Andrea;
    • Haspinger, Eva Regina;
    • Caldara, Alessia
    Publication type:
    Article
    46

    Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
    By:
    • Fabi, Alessandra;
    • Carbognin, Luisa;
    • Botticelli, Andrea;
    • Paris, Ida;
    • Fuso, Paola;
    • Savastano, Maria Cristina;
    • La Verde, Nicla;
    • Strina, Carla;
    • Pedersini, Rebecca;
    • Guarino, Stefania;
    • Curigliano, Giuseppe;
    • Criscitiello, Carmen;
    • Raffaele, Mimma;
    • Beano, Alessandra;
    • Franco, Antonio;
    • Valerio, Maria Rosaria;
    • Verderame, Francesco;
    • Fontana, Andrea;
    • Haspinger, Eva Regina;
    • Caldara, Alessia
    Publication type:
    Article
    47

    CORRESPONDENCE.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 22, p. 1719
    By:
    • Milella, Michele;
    • Giannarelli, Diana;
    • Ferraresi, Virginia;
    • Mottolese, Marcella;
    • Botti, Claudio;
    • Nisticò, Cecilia;
    • Ferretti, Gianluigi;
    • Di Cosimo, Serena;
    • Carlini, Paolo;
    • Papaldo, Paola;
    • Fabi, Alessandra;
    • Cognetti, Francesco;
    • Hrushesky, William J.M.;
    • Love, Richard R.;
    • Allred, D. Craig;
    • DeMets, David L.;
    • Hortobagyi, Gabriel
    Publication type:
    Article
    48

    Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1177681
    By:
    • Fabbri, Agnese;
    • Nelli, Fabrizio;
    • Botticelli, Andrea;
    • Giannarelli, Diana;
    • Marrucci, Eleonora;
    • Fiore, Cristina;
    • Virtuoso, Antonella;
    • Scagnoli, Simone;
    • Pisegna, Simona;
    • Alesini, Daniele;
    • Sini, Valentina;
    • Orlandi, Armando;
    • Fabi, Alessandra;
    • Piacentini, Federico;
    • Moscetti, Luca;
    • D’Auria, Giuliana;
    • Gamucci, Teresa;
    • Mazzotta, Marco;
    • Pizzuti, Laura;
    • Vici, Patrizia
    Publication type:
    Article
    49

    Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1053035
    By:
    • De Paolis, Elisa;
    • Paris, Ida;
    • Tilocca, Bruno;
    • Roncada, Paola;
    • Foca, Laura;
    • Tiberi, Giordana;
    • D'Angelo, Tatiana;
    • Pavese, Francesco;
    • Muratore, Margherita;
    • Carbognin, Luisa;
    • Garganese, Giorgia;
    • Masetti, Riccardo;
    • Di Leone, Alba;
    • Fabi, Alessandra;
    • Scambia, Giovanni;
    • Urbani, Andrea;
    • Generali, Daniele;
    • Minucci, Angelo;
    • Santonocito, Concetta
    Publication type:
    Article
    50